Phase I/II clinical trial for aGalCer resembling medicine,OCH in patients with Crohn s disease
Phase 1
- Conditions
- Crohn disease
- Registration Number
- JPRN-UMIN000023525
- Lead Sponsor
- School of Medicine, Keio University Department of Internal Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
Not provided
Exclusion Criteria
1) The patient who is suspected as other inflammatory bowel disease except Crohn s disease 2) Patient who will need bowel resection within 12 weeks after the entry of clinical trial. 3) Patient who is entering to another clinical trial or who receive medical treatment in any other clinical trial within 12 weeks prior to entry of the present clinical trial. others criteria can not uploaded due to the space.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adverse event
- Secondary Outcome Measures
Name Time Method Clinical efficacy Pharmacokinetics of OCH Pharmacodynamics of OCH